| Colarusso, Thomas (Definiens 201106 VP Sales + Operations at Definiens Inc.) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
United States (USA) |
| Cole, Alun (Markes International 200908 Director of ALMSCO International division) |
President/Director/Head Business Group/Unit/Division |
Schauenburg (Group) |
United Kingdom (GB) |
| Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
| Coles, Anthony (Tony) (Cerevel 201909– CEO before Yumanity Therapeutics + Onyx + NPS + Vertex + BMS + Merck US) |
Chief Executive Officer (CEO) |
Cerevel Therapeutics LLC |
United States (USA) |
| Colinge, Jacques (Austrian Academi of Sciences 201202 Ce-M-M-Research Center for Molecular Medicine) |
Researcher (university / research institute) |
Austrian Academy of Sciences (ÖAW) |
Austria |
| Collasius, Michael (Qiagen 200705 VP Automated Systems) |
n. a. |
Qiagen (Group) |
Germany |
| Collins, John |
n. a. |
Cosmix (Group) |
Germany |
| Collins, Peter (4titude Ltd 201710 Co-Founder) |
Company Founder |
Brooks Automation (Group) |
United Kingdom (GB) |
| Colloca, Stefano (Nouscom 201806 CTO) |
Chief Technology/Technical Officer (CTO) |
Nouscom (Group) |
Switzerland |
| Colpan, Metin (Qiagen CEO + co-founder) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
Germany |
| Comb, Michael J. (Cell Signaling Technology 200907 CEO + Founder) |
Chief Executive Officer (CEO) |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
| Combal, Jean-Philippe (Vivet Therapeutics 201705 CEO + Co-Founder before Gensight Biologics + Sanofi) |
Chief Executive Officer (CEO) |
Vívet Therapeutics (Group) |
France |
| Combé, Nicolas (Nanohale 201102 CFO) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Germany |
| Compton, Carolyn (Arizon State Univ + Mayo Clinic 201502 Professor + former Director of NCI OBBR) |
Professor |
Arizona State University (ASU) |
United States (USA) |
| Conca, James (RJ Lee Group 201306 Director Analytical Services) |
President/Director/Head Business Group/Unit/Division |
RJ Lee Group Inc. |
United States (USA) |
| Condie, Jamie (BD Diagnostics 200807 VP + General Manger) |
n. a. |
Becton, Dickinson (Group) |
United States (USA) |
| Condon, Liam (Bayer 201212– CEO of Bayer CropScience before Managing Director Bayer Vital before Schering) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
| Connelly, Robert T. (Elicio Therapeutics 201903– CEO before Pronutria + Pulmatrix + Diversys/Domantis + IGEN Intl) |
Chief Executive Officer (CEO) |
|
|
| Conni, Mario (Eurofins 201410– Managing Director of Eurofins Genomics Srl) |
Managing Director |
Eurofins (Group) |
Italy |
| Connor, Ed (Peak Scientific 201302– GC/MS Product Specialist before ETHZ + Univ Zürich) |
Support Manager / Service Manager |
Peak Scientific (Group) |
United Kingdom (GB) |
| Conquet, Francois (Prexton Therapeutics 201207– CEO + founder) |
Chief Executive Officer (CEO) |
Lundbeck (Group) |
Switzerland |
| Conradt, Monika (Evotec 201606– Global Head Human Resources before Boehringer HR Manager Europe) |
Human Resources Manager |
Evotec (Group) |
Germany |
| Constant, Samuel (Epithelix 201207 COO + Co-founder) |
Chief Operating Officer (COO) |
Epithelix Sàrl |
Switzerland |
| Conterno, Enrique (Eli Lilly 199201– President Lilly USA) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Conway, Christopher (ABCell-Bio SAS 201508 CEO) |
Chief Executive Officer (CEO) |
ABCell-Bio S.A.S. |
France |
| Cooley, Margaret M. (Photonis 201512 International Marketing Manager at Photonis USA) |
Sales Manager / Marketing Manager |
Photonis (Group) |
United States (USA) |
| Coon, Joshua (Univ Wisconsin 201506 Professor) |
Professor |
University of Wisconsin System |
United States (USA) |
| Cooper, Ashley (Reinnervate 200709– CEO) |
Chief Executive Officer (CEO) |
ReproCell (Group) |
United Kingdom (GB) |
| Coorey, David (Agena Bioscience 201607– VP + Managing Director EMEA before BD + Affymetrix + Gambro + Fresenius Kabi) |
Regional manager |
Agena Bioscience Inc. |
United States (USA) |
| Coppard, Nicholas (Santhera 201502– appointed SVP Head Development) |
Research & Development Manager |
Santhera (Group) |
Switzerland |
| Coquoz, Didier (Oncalis 200810 CEO) |
Chief Executive Officer (CEO) |
Oncalis AG |
Switzerland |
| Corazza, Sabrina (Axxam 201603 Director Business Development) |
Business Development Manager / Strategy Manager |
Axxam S.p.A. |
Italy |
| Corbett, Jim (PerkinElmer 201207 President Diagnostics) |
President/Director/Head Business Group/Unit/Division |
PerkinElmer (Group) |
United States (USA) |
| Cordes, Ralf (Ascienion 200902 Technology Manager) |
IP Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Cordes, Ulrik (Biocartis 201309– CCO before Thermo Fisher + Dako A/S + Pharmacia Biotech A/S) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Switzerland |
| Cornett, Shannon (Bruker 201305 Applications Developm Manager) |
Research & Development Manager |
Bruker Corporation (Group) |
United States (USA) |
| Corr, David (EKF Diagnostics 201307– CTO before Head of RnD) |
Chief Technology/Technical Officer (CTO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Corr, Peter B. (Celtic Therapeutics 2007 Managing General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
| Corriveau, Jacques (AstraZeneca 201711– General Manager North America at Definiens) |
General Manager (management) |
AstraZeneca (Group) |
United States (USA) |
| Corsico, Christopher (Boehringer 201708 CMO) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Corsini, Lorenzo (PhagoMed 201910 Co-CEO + Co-Founder) |
Chief Executive Officer (CEO) |
PhagoMed Biopharma GmbH |
Austria |
| Cortese, Riccardo (Nouscom 201605 CEO + Co-Founder before Okairos CEO + co-founder) |
Chief Executive Officer (CEO) |
Nouscom (Group) |
Switzerland |
| Corvaïa, Nathalie (Pierre Fabre 201404 Managing Director of Center of Immunology Pierre Fabre) |
Managing Director |
Pierre Fabre (Group) |
France |
| Cospedal, Rosario (Zeltia 201211 CEO of Genomica S.A.U.) |
Chief Executive Officer (CEO) |
PharmaMar (Group) |
Spain (España) |
| Costantin, James (Nanion 201807 Director Customer Relations located at US West Coast Office) |
Sales Manager / Marketing Manager |
Nanion (Group) |
United States (USA) |
| Costantini, Dominique (OSE Pharma 201504 CEO + Co-founder + former CEO + Co-founder of BioAlliance Pharma in 1997) |
Chief Executive Officer (CEO) |
OSE Immunotherapeutics (Group) |
France |
| Cotte, Yann (Nanolive 201602 Managing Director) |
Managing Director |
Nanolive S.A. |
Switzerland |
| Cottier, Gilles (Sigma-Aldrich 201004 President SAFC) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Cottier, Gilles (Sigma-Aldrich 201504 EVP + President SAFC Commercial) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Cottier, Kaspar (Creoptix 201912– CTO + Founder) |
Chief Technology/Technical Officer (CTO) |
Creoptix AG |
Switzerland |
| Couch, Gregory (Radimetrics 2009– CEO + Founder) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Canada |
| Coucke, Marc (Alychlo before Omega Pharma 1987– CEO + Founder) |
Chief Executive Officer (CEO) |
Alychlo (Marc Coucke) |
|
| Coughlin, Robert K. (MBC 200904 President + CEO) |
Chief Executive Officer (CEO) |
Massachusetts Biotechnology Council (MassBio / MBC) |
United States (USA) |
| Coukos, George (Univ Lausanne 201601 Prof + Director of Ludwig Institute for Cancer Research) |
Professor |
University of Lausanne (UNIL) |
Switzerland |
| Coulter, Bianca (Coulter Partners 201711 CEO) |
Chief Executive Officer (CEO) |
Coulter Partners (The Coulter Partnership Ltd.) |
United Kingdom (GB) |
| Courtine, Grégoire (EPFL + CHUV 201604 + G-Therapeutics 201604 CSO + Co-Founder) |
Professor |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| Coutanceau, Emmanuelle (Novo Group 201705 Novo Seeds before Auriga Partners) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Coutet, Matthieu (Advent France Biotechnology 201704 Managing Partner before Inserm Transfert) |
Managing Partner (investment firm) |
Advent France Biotechnology S.A.S. |
France |
| Couttie, John (Peak Scientific 201310 General Manager Americas) |
General Manager (management) |
Peak Scientific (Group) |
United States (USA) |
| Cowan, Chad (CRISPR Therapeutics 201705 Head of Research) |
Researcher (industry) |
CRISPR Therapeutics (Group) |
Switzerland |
| Cowan, David (Univ London 1990– Professor + Director Drug Control Centre King’s College) |
Professor |
University of London |
United Kingdom (GB) |
| Cowling, Didier (Kuros 200807 CEO) |
Chief Executive Officer (CEO) |
Kuros (Group) |
Switzerland |
| Cox, Jürgen (Max Planck 200705 MPI for Biochemistry) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Cox, Russel J. (Russ) (Epirium Bio 201912 CEO before Vital Therapies + Jazz Pharmaceuticals + Ipsen + Genentech) |
Chief Executive Officer (CEO) |
Epirium Bio Inc. |
|
| Cox, Steve |
n. a. |
Commerzbank (Group) |
Germany |
| Craft, Noah (Science 37 201703 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Science 37 Inc. |
United States (USA) |
| Craig, Frank F. (Sphere Fluidics 201711 CEO) |
Chief Executive Officer (CEO) |
Sphere Fluidics (Group) |
United Kingdom (GB) |
| Cramer, Patrick (LMU 201201 Professor + since 2004 Director of LMU Gene Center Munich) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München) |
Germany |
| Crawford, Bill (Roche 201112 Director of Marketing, Discovery at Ventana) |
Sales Manager / Marketing Manager |
Roche (Group) |
United States (USA) |
| Creasey, Theresa S. (Sigma-Aldrich 201411 VP Diagnostics + Testing of Applied Business Unit) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Cresswell, Warren (Nestlé 201707 General Manager + Head of Prometheus Diagnostics + CEO of MDP) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
United States (USA) |
| Crook, Jayne (Instinctif Partners 201603) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
| Crooke, Stanley T. (Isis Pharmaceuticals 200604 CEO) |
Chief Executive Officer (CEO) |
Ionis Pharmaceuticals (Group) |
United States (USA) |
| Crowe, Joanne (MorphoSys AbD –200603– Head Sales + Marketing) |
Sales Manager / Marketing Manager |
Bio-Rad (Group) |
Germany |
| Crowley, Erin (Q Laboratories 201802 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Q Laboratories Inc. |
United States (USA) |
| Crutchfield, Brad (Qiagen 201506–2016 SVP before Illumina + NanoString + Bio-Rad STEPPED DOWN 2016) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Netherlands |
| Ctortecka, Bernd (Max Planck 200908 Patent + License Manager Max Planck Innovation GmbH) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Cullmann, Hans (Comicon GmbH 201101 Managing Director + Founder + 45% Owner) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Culp, H. Lawrence, Jr. (Danaher 2001–201502 CEO RETIRED 3/15) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Cunha, Fernando (AB2 Bio 201602 CFO) |
Chief Financial Officer (CFO) |
AB2 Bio S.A. |
Switzerland |
| Cunningham, Craig (Maine Manufacturing 2007– Founder + VP Engineering + Development) |
Research & Development Manager |
GVS (IT) (Group) |
United States (USA) |
| Cunningham, David (Royal Marsden Hospital 200909 Head Gastrointestinal Unit) |
Professor |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Currie, Ed (SIRS-Lab 200902– Executive VP Corp Development before Kuros BioSurgery before Lilly + Roche + IBM) |
Business Development Manager / Strategy Manager |
Endress+Hauser (Group) |
Germany |
| Curtin, Francois (Geneuro 201207 CEO) |
Chief Executive Officer (CEO) |
GeNeuro S.A. (Euronext Paris: GNRO) |
Switzerland |
| Curtis, Andrew (Affimed 201512– before Pfizer 2008– 2014 Head Corporate Strategy + BusDev before Jerini US + Genzmye) |
Business Development Manager / Strategy Manager |
Affimed (Group) |
United States (USA) |
| Curtis, Michael (Cadent Therapeutics 201811 CEO) |
Chief Executive Officer (CEO) |
Cadent Therapeutics (US) |
United States (USA) |
| Curvers, Simon (Direvo 201101– Director R&D before at Direvo since 200711 + AC Biotech 200101–200905 Managing Director) |
Research & Development Manager |
Direvo Industrial Biotechnology (Group) |
Germany |
| Cuss, Francis (BMS 201410 EVP + CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Cuypers, Heinrich (BioCon Valley 201105 Senior Project Manager) |
n. a. |
BioCon Valley GmbH |
Germany |
| Czerepak, Elizabeth A. (Isarna Therapeutics 201404– CFO/CBO based in US before Bear Stearns Health Innoventures) |
Chief Financial Officer (CFO) |
Bear Stearns (Group) |
United States (USA) |
| Czerney, Peter (Dyomics 200301 Managing Director + Founder) |
Managing Director |
Dyomics GmbH |
Germany |
| da Silva, Nino (BC Platforms 201912 EVP EMEA-APAC) |
Regional manager |
BC Platforms (Group) |
Switzerland |
| Dabrowski, Michael (Pelago Bioscience AB 201506 CEO) |
Chief Executive Officer (CEO) |
Pelago Bioscience AB |
Sweden |
| Dabrowski, Tomasz (Dentons 201412 Europe CEO) |
Chief Executive Officer (CEO) |
Dentons (Group) |
Switzerland |
| Dabu, Ferdinand (SGS 201011 Global Marketing Director Life Sciences Services R&D/QC) |
Sales Manager / Marketing Manager |
SGS (Group) |
Switzerland |
| Dachis, Jeffrey A. (Jeff) (Informed Data Systems 201909 CEO + Founder) |
Chief Executive Officer (CEO) |
Informed Data Systems Inc. |
United States (USA) |
| Dadswell, Charles (Illumina 201604 SVP + General Counsel) |
General Counsel / Chief Legal Officer (CLO) |
Illumina (Group) |
United States (USA) |
| Daglinger, Birgit (Ferring 201210 Managing Director of Ferring Arzneimittel GmbH) |
Managing Director |
Ferring (Paulsen Foundation) (Group) |
Germany |
| Dahiyat, Bassil (Xencor 200607 President + CEO) |
Chief Executive Officer (CEO) |
Xencor Inc. (Nasdaq: XNCR) |
United States (USA) |
| Dahlhauser, Eric B. (Insight Genetics 201201 CEO before Genetics Assays CEO) |
Chief Executive Officer (CEO) |
Insight Genetics Inc. |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 10 11 12 ... 68 69 70 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
